Cargando…

Thoracic SMARCA4-deficient undifferentiated tumor—a case of an aggressive neoplasm—case report

Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are aggressive neoplasms that most commonly occur in the mediastinum of male smokers. These tumors are characterized by an inactivating mutation of SMARCA4 resulting in loss of expression of brahma-related gene 1 (BRG1). These tumors ca...

Descripción completa

Detalles Bibliográficos
Autor principal:	Roden, Anja C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794332/ https://www.ncbi.nlm.nih.gov/pubmed/35118344 http://dx.doi.org/10.21037/med-20-15

Ejemplares similares

SMARCA4-deficient undifferentiated thoracic tumor: A case report
por: Kwon, Hee Jung, et al.
Publicado: (2023)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Thoracic SMARCA4‐deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report
por: Takemura, Chihiro, et al.
Publicado: (2023)

A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab
por: Nakano, Yoshio, et al.
Publicado: (2022)

Thoracic SMARCA4-Deficient Undifferentiated Tumor With ALK Fusion Treated With Alectinib Achieved Remarkable Tumor Regression: Case Report
por: Sheng, Jin, et al.
Publicado: (2023)

Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report
por: Yang, Pan, et al.
Publicado: (2023)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure
por: Ito, Shotaro, et al.
Publicado: (2021)

Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
por: Kunimasa, Kei, et al.
Publicado: (2021)

SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report
por: Utsumi, Takahiro, et al.
Publicado: (2022)

Diagnosis of a SMARCA4 ‐deficient undifferentiated tumor using multigene panel testing: A case report
por: Marumo, Yoshiaki, et al.
Publicado: (2023)

Thoracic SMARCA4‐deficient undifferentiated tumour: Diagnostic challenges and potential for misdiagnosis in small tissue samples
por: Maartens, Deborah Johanna, et al.
Publicado: (2023)

Case report: A rapid response to immunotherapy in a thoracic SMARCA4-deficient undifferentiated tumor with respiratory failure
por: Shi, Liyong, et al.
Publicado: (2022)

Case Series of SMARCA4-Deficient Undifferentiated Esophageal Carcinoma
por: Ahmed, Omar T, et al.
Publicado: (2022)

A dramatic course after the resection of an SMARCA4‐deficient undifferentiated tumour
por: Iguchi, Takafumi, et al.
Publicado: (2022)

SMARCA4-Deficient Undifferentiated Tumor of Lung Mass—A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature
por: Yadav, Ruchi, et al.
Publicado: (2022)

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
por: Lin, Ying, et al.
Publicado: (2023)

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors
por: Gantzer, Justine, et al.
Publicado: (2022)

SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
por: Rekhtman, Natasha, et al.
Publicado: (2019)

SMARCA4-deficient thoracic tumor detected by [(18)F]FDG PET/CT
por: Okazaki, Tsubasa, et al.
Publicado: (2021)

SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site
por: Tono, Yasutaka, et al.
Publicado: (2022)

Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
por: Meng, Xiangpeng, et al.
Publicado: (2023)

Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report
por: Kito, Yusuke, et al.
Publicado: (2022)

Is the case really a SMARCA4‐deficient thoracic sarcoma?
por: Kunimasa, Kei
Publicado: (2020)

A Case Report of SMARCA4-Deficient Thoracic Sarcoma: A Rare and Aggressive Disease With a Grim Prognosis
por: Lalaoui Rachidi, Siham, et al.
Publicado: (2023)

Notable Response of SMARCA4-Deficient Undifferentiated Uterine Sarcoma to Palliative Radiation Therapy
por: Kurokawa, Mariko, et al.
Publicado: (2021)

SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
por: Al-Shbool, Ghassan, et al.
Publicado: (2022)

Response to ‘Is the case really a SMARCA4‐deficient thoracic sarcoma?’
por: Takada, Kohichi, et al.
Publicado: (2020)

Highly aggressive undifferentiated small round blue cell tumor of foot with unique SMARCA1, KAT6A and NAV3 mutations
por: Parsa, Cyrus, et al.
Publicado: (2019)

Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma
por: Gao, Jie, et al.
Publicado: (2023)

Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report
por: Takada, Kohichi, et al.
Publicado: (2019)

Synchronous Malignant Gastrointestinal Neuroectodermal Tumor and SMARCA4-Deficient Undifferentiated Carcinoma With Independent Origins in the Small Intestine: A Case Report
por: Chen, Cuimin, et al.
Publicado: (2021)

Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): A case report
por: Baa, Annie Kanchan, et al.
Publicado: (2021)

SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma
por: Khanchel, Fatma, et al.
Publicado: (2021)

Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study
por: Anžič, Nina, et al.
Publicado: (2021)

Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot
por: Agaimy, Abbas, et al.
Publicado: (2021)

SMARCA4‑deficient non‑small cell lung cancer with an EGFR mutation: A case report
por: Sun, Lijun, et al.
Publicado: (2023)

Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
por: Lin, Yun-Tzu, et al.
Publicado: (2023)

SMARCA4‐deficient lung tumour that presented with haemoptysis and progressed rapidly
por: Inoue, Mari, et al.
Publicado: (2020)

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report
por: Naito, Tomoyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ibbqbvolvbj748avhf0heeqni7